Dx-890    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis4

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
4 / 1,592 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-002341-12-BE
(EUCTR)
05/08/200525/08/2005Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762
Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase
Debiopharm SANULLNot RecruitingFemale: yes
Male: yes
90United Kingdom;Germany;Belgium;Italy
2EUCTR2004-002341-12-GB
(EUCTR)
15/04/200510/02/2005Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762
Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase
Debiopharm SANULLNot RecruitingFemale: yes
Male: yes
90Phase 2Belgium;Germany;Italy;United Kingdom
3EUCTR2004-002341-12-DE
(EUCTR)
14/02/200524/09/2004Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients Cystic fibrosis
MedDRA version: 7.0;Level: PT;Classification code 10011762
Product Name: Depelestat
Product Code: EPI-hNE4 DX-890
INN or Proposed INN: Depelestat
Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase
INN or Proposed INN: Depelestat
Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase
Debiopharm SANULLNot RecruitingFemale: yes
Male: yes
90United Kingdom;Germany;Belgium;Italy
4EUCTR2004-002341-12-IT
(EUCTR)
12/01/200516/03/2005Multicenter, 8-week, Randomised,Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis PatientsMulticenter, 8-week, Randomised,Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients cystic fibrosis
MedDRA version: 6.1;Level: PT;Classification code 10011762
Product Name: DEPELESTAT
Product Code: DX-890
INN or Proposed INN: Other respiratory system products
Product Name: DEPELESTAT
Product Code: DX-890
INN or Proposed INN: Other respiratory system products
DEBIOPHARM S.A.NULLNot RecruitingFemale: yes
Male: yes
90United Kingdom;Germany;Belgium;Italy